PMGC Holdings (ELAB) EPS (Basic) Growth (1y) (2023 - 2026)
PMGC Holdings (ELAB) EPS (Basic) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -16.29% |
| 10 | PMGC Holdings | 31.06 Mn | 12.27 Mn | 385,691.00 | -176.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.03% |
| Dec 31, 2025 | 100.47% |
| Sep 30, 2025 | 100.06% |
| Jun 30, 2025 | 100.02% |
| Mar 31, 2025 | 99.97% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 99.95% |
| Jun 30, 2024 | 55.71% |
| Mar 31, 2024 | -25.25% |
| Dec 31, 2023 | -143.87% |
| Sep 30, 2023 | 45.11% |